4 Stem Cell Stocks To Watch: ASTM, BTX, ACTC, NBS

February was a tough month for biotech stocks researching stem cells for the treatment and cure of diseases. TickerSpy’s Stem Cell Stocks Index (RXSTM) has slipped nearly 13% since early February being outperformed by the S&P 500 by close to 17% during that time.

Four particular stem cell stocks, all cheap stocks under 5 including 2 penny stocks, should be added to investor radars immediately. Despite the recent drop in investor optimism, the companies of the following stem cell stocks are continuing to lead towards new and promising research which continues to propel the industry forward.

Aastrom Biosciences, Inc. (Nasdaq: ASTM)

  • Pre Market PPS: $1.85
  • % Change from 50-Day Moving Average: -3.07%,  1.91
  • % Change from 200-Day Moving Average: -16.00%,  2.20
  • 52-Week Range: 1.75 –  3.47
  • Short Ratio: 14.20

BioTime, Inc. (Amex: BTX)

  • Pre Market PPS: $4.97
  • % Change from 50-Day Moving Average: -10.39%,  5.55
  • % Change from 200-Day Moving Average: 1.26%,  4.91
  • 52-Week Range: 3.55 – 8.21
  • Short Ratio: 36.90

Neostem, Inc. (Amex: NBS)

  • Pre Market PPS: $0.5602
  • % Change from 50-Day Moving Average: -12.55%,  0.64
  • % Change from 200-Day Moving Average: -10.33%,  0.62
  • 52-Week Range: 0.43 – 2.10
  • Short Ratio: 5.60

Advanced Cell Technology (OTCQB: ACTC.OB)

  • Pre Market PPS: $0.1015
  • % Change from 50-Day Moving Average: -15.42%,  0.12
  • % Change from 200-Day Moving Average: -32.33%,  0.15
  • 52-Week Range: 0.08 – 0.22
  • Short Ratio: N/A

New studies conducted at Johns Hopkins University have proven that stem cells from a patients’ own cardiac tissue can be used to heal scarred tissue after a heart attack. In another stem cell study, researchers led by Jonathan Tilly, director of the Vincent Center for Reproductive Biology at Massachusetts General Hospital, believe they’ve discovered that the ovaries of young women harbor very rare stem cells which are capable of producing new eggs.

Add these four stocks to your watch list as stem cell research has been controversial for many years but any breakthrough could send any one of these stocks surging and possibly make them a candidate for a takeover.

Last updated by at .

0
  Recent Penny Stock News